Cargando…

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans

BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to un...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xianyuan, Piers, Thomas M., Wefers, Benedikt, Zhu, Kaichuan, Mallach, Anna, Brunner, Bettina, Kleinberger, Gernot, Song, Wilbur, Colonna, Marco, Herms, Jochen, Wurst, Wolfgang, Pocock, Jennifer M., Haass, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126019/
https://www.ncbi.nlm.nih.gov/pubmed/30185230
http://dx.doi.org/10.1186/s13024-018-0280-6
_version_ 1783353256743796736
author Xiang, Xianyuan
Piers, Thomas M.
Wefers, Benedikt
Zhu, Kaichuan
Mallach, Anna
Brunner, Bettina
Kleinberger, Gernot
Song, Wilbur
Colonna, Marco
Herms, Jochen
Wurst, Wolfgang
Pocock, Jennifer M.
Haass, Christian
author_facet Xiang, Xianyuan
Piers, Thomas M.
Wefers, Benedikt
Zhu, Kaichuan
Mallach, Anna
Brunner, Bettina
Kleinberger, Gernot
Song, Wilbur
Colonna, Marco
Herms, Jochen
Wurst, Wolfgang
Pocock, Jennifer M.
Haass, Christian
author_sort Xiang, Xianyuan
collection PubMed
description BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to understand the TREM2 related dysfunctions responsible for the enhanced risk for late onset Alzheimer’s disease. METHODS: A CRISPR/Cas9-assisted gene targeting strategy was used to generate Trem2 R47H knock-in mice. Trem2 mRNA and protein levels as well as Trem2 splicing patterns were assessed in these mice, in iPSC-derived human microglia-like cells, and in human brains from Alzheimer’s patients carrying the TREM2 R47H risk factor. RESULTS: Two independent Trem2 R47H knock-in mouse models show reduced Trem2 mRNA and protein production. In both mouse models Trem2 haploinsufficiency was due to atypical splicing of mouse Trem2 R47H, which introduced a premature stop codon. Cellular splicing assays using minigene constructs demonstrate that the R47H variant induced abnormal splicing only occurs in mice but not in humans. TREM2 mRNA levels and splicing patterns were both normal in iPSC-derived human microglia-like cells and patient brains with the TREM2 R47H variant. CONCLUSIONS: The Trem2 R47H variant activates a cryptic splice site that generates miss-spliced transcripts leading to Trem2 haploinsufficiency only in mice but not in humans. Since Trem2 R47H related phenotypes are mouse specific and do not occur in humans, humanized TREM2 R47H knock-in mice should be generated to study the cellular consequences caused by the human TREM2 R47H coding variant. Currently described phenotypes of Trem2 R47H knock-in mice can therefore not be translated to humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-018-0280-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6126019
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61260192018-09-10 The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans Xiang, Xianyuan Piers, Thomas M. Wefers, Benedikt Zhu, Kaichuan Mallach, Anna Brunner, Bettina Kleinberger, Gernot Song, Wilbur Colonna, Marco Herms, Jochen Wurst, Wolfgang Pocock, Jennifer M. Haass, Christian Mol Neurodegener Research Article BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to understand the TREM2 related dysfunctions responsible for the enhanced risk for late onset Alzheimer’s disease. METHODS: A CRISPR/Cas9-assisted gene targeting strategy was used to generate Trem2 R47H knock-in mice. Trem2 mRNA and protein levels as well as Trem2 splicing patterns were assessed in these mice, in iPSC-derived human microglia-like cells, and in human brains from Alzheimer’s patients carrying the TREM2 R47H risk factor. RESULTS: Two independent Trem2 R47H knock-in mouse models show reduced Trem2 mRNA and protein production. In both mouse models Trem2 haploinsufficiency was due to atypical splicing of mouse Trem2 R47H, which introduced a premature stop codon. Cellular splicing assays using minigene constructs demonstrate that the R47H variant induced abnormal splicing only occurs in mice but not in humans. TREM2 mRNA levels and splicing patterns were both normal in iPSC-derived human microglia-like cells and patient brains with the TREM2 R47H variant. CONCLUSIONS: The Trem2 R47H variant activates a cryptic splice site that generates miss-spliced transcripts leading to Trem2 haploinsufficiency only in mice but not in humans. Since Trem2 R47H related phenotypes are mouse specific and do not occur in humans, humanized TREM2 R47H knock-in mice should be generated to study the cellular consequences caused by the human TREM2 R47H coding variant. Currently described phenotypes of Trem2 R47H knock-in mice can therefore not be translated to humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-018-0280-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-06 /pmc/articles/PMC6126019/ /pubmed/30185230 http://dx.doi.org/10.1186/s13024-018-0280-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xiang, Xianyuan
Piers, Thomas M.
Wefers, Benedikt
Zhu, Kaichuan
Mallach, Anna
Brunner, Bettina
Kleinberger, Gernot
Song, Wilbur
Colonna, Marco
Herms, Jochen
Wurst, Wolfgang
Pocock, Jennifer M.
Haass, Christian
The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title_full The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title_fullStr The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title_full_unstemmed The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title_short The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
title_sort trem2 r47h alzheimer’s risk variant impairs splicing and reduces trem2 mrna and protein in mice but not in humans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126019/
https://www.ncbi.nlm.nih.gov/pubmed/30185230
http://dx.doi.org/10.1186/s13024-018-0280-6
work_keys_str_mv AT xiangxianyuan thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT piersthomasm thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT wefersbenedikt thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT zhukaichuan thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT mallachanna thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT brunnerbettina thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT kleinbergergernot thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT songwilbur thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT colonnamarco thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT hermsjochen thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT wurstwolfgang thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT pocockjenniferm thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT haasschristian thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT xiangxianyuan trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT piersthomasm trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT wefersbenedikt trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT zhukaichuan trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT mallachanna trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT brunnerbettina trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT kleinbergergernot trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT songwilbur trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT colonnamarco trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT hermsjochen trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT wurstwolfgang trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT pocockjenniferm trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans
AT haasschristian trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans